[1] |
Takahashi K, Yamanaka S. A decade of transcription factor⁃mediated reprogramming to pluripotency[J]. Nat Rev Mol Cell Biol, 2016,17(3):183⁃193. doi: 10.1038/nrm.2016.8.
|
[2] |
Brix J, Zhou Y, Luo Y. The epigenetic reprogramming roadmap in generation of iPSCs from somatic cells[J]. J Genet Genomics, 2015,42(12):661⁃670. doi: 10.1016/j.jgg.2015.10.001.
|
[3] |
Teshigawara R, Cho J, Kameda M, et al. Mechanism of human somatic reprogramming to iPS cell[J]. Lab Invest, 2017,97(10):1152⁃1157. doi: 10.1038/labinvest.2017.56.
|
[4] |
Nishiguchi M, Kikuyama H, Kanazawa T, et al. Increases in iPS transcription factor (Oct4, Sox2, c⁃Myc, and Klf4) gene after modified electroconvulsive therapy[J]. Psychiatry Investig, 2015,12(4):532⁃537. doi: 10.4306/pi.2015. 12.4.532.
|
[5] |
Yang F, Wang N, Wang Y, et al. Activin⁃SMAD signaling is required for maintenance of porcine iPS cell self⁃renewal through upregulation of NANOG and OCT4 [J]. J Cell Physiol, 2017,232(8):2253⁃2262. doi: 10.1002/jcp.25747.
|
[6] |
Hoang P, Wang J, Conklin BR, et al. Generation of spatial⁃patterned early⁃developing cardiac organoids using human pluripotent stem cells[J]. Nat Protoc, 2018,13(4):723⁃737. doi: 10.1038/nprot.2018.006.
|
[7] |
Osaki T, SGM U, Kamm RD. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS⁃derived muscle cells and optogenetic motor neurons[J]. Sci Adv, 2018,4(10):eaat5847. doi: 10.1126/sciadv.aat5847.
|
[8] |
Ishida Y, Kawakami H, Kitajima H, et al. Vulnerability of Purkinje cells generated from spinocerebellar ataxia type 6 patient⁃derived iPSCs[J]. Cell Rep, 2016,17(6):1482⁃1490. doi: 10.1016/j.celrep.2016.10.026.
|
[9] |
Mandai M, Watanabe A, Kurimoto Y, et al. Autologous induced stem⁃cell⁃derived retinal cells for macular degeneration[J]. N Engl J Med, 2017,376(11):1038⁃1046. doi: 10.1056/NEJMoa 1608368.
|
[10] |
Gledhill K, Guo Z, Umegaki⁃Arao N, et al. Melanin transfer in human 3D skin equivalents generated exclusively from induced pluripotent stem cells[J/OL]. PLoS One, 2015,10(8):e0136713. [2018⁃08⁃03]. https://journals.plos.org/plosone/article?id=10.1371/ journal.pone.0136713. doi: 10.1371/journal.pone.0136713.
|
[11] |
Yang R, Zheng Y, Burrows M, et al. Generation of folliculogenic human epithelial stem cells from induced pluripotent stem cells[J]. Nat Commun, 2014,5:3071. doi: 10.1038/ncomms4071.
|
[12] |
Kim Y, Park N, Rim YA, et al. Establishment of a complex skin structure via layered co⁃culture of keratinocytes and fibroblasts derived from induced pluripotent stem cells[J]. Stem Cell Res Ther, 2018,9(1):217. doi: 10.1186/s13287⁃018⁃0958⁃2.
|
[13] |
Umegaki⁃Arao N, Pasmooij AM, Itoh M, et al. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa[J]. Sci Transl Med, 2014,6(264):264ra164. doi: 10.1126/scitranslmed.3009342.
|
[14] |
Koehler KR, Hashino E. 3D mouse embryonic stem cell culture for generating inner ear organoids[J]. Nat Protoc, 2014,9(6):1229⁃1244. doi: 10.1038/nprot.2014.100.
|
[15] |
Lee J, Böscke R, Tang PC, et al. Hair follicle development in mouse pluripotent stem cell⁃derived skin organoids[J]. Cell Rep, 2018,22(1):242⁃254. doi: 10.1016/j.celrep.2017.12.007.
|
[16] |
Takagi R, Ishimaru J, Sugawara A, et al. Bioengineering a 3D integumentary organ system from iPS cells using an in vivo transplantation model[J]. Sci Adv, 2016,2(4):e1500887. doi: 10.1126/sciadv.1500887.
|
[17] |
Itoh M, Umegaki⁃Arao N, Guo Z, et al. Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs)[J/OL]. PLoS One, 2013,8(10):e77673. [2018⁃08⁃03]. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0077673. doi: 10. 1371/journal.pone.0077673.
|
[18] |
Matsumura W, Fujita Y, Nakayama C, et al. Establishment of integration⁃free induced pluripotent stem cells from human recessive dystrophic epidermolysis bullosa keratinocytes[J]. J Dermatol Sci, 2018,89(3):263⁃271. doi: 10.1016/j.jdermsci.2017. 11.017.
|
[19] |
Shalom⁃Feuerstein R, Serror L, Aberdam E, et al. Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia⁃related patients is rescued by the small compound APR⁃246/PRIMA⁃1MET[J]. Proc Natl Acad Sci U S A, 2013,110(6):2152⁃2156. doi: 10.1073/pnas.1201753109.
|
[20] |
El⁃Darouti M, Fawzy M, Amin I, et al. Treatment of dystrophic epidermolysis bullosa with bone marrow non⁃hematopoeitic stem cells: a randomized controlled trial[J]. Dermatol Ther, 2016,29(2):96⁃100. doi: 10.1111/dth.12305.
|
[21] |
Iinuma S, Aikawa E, Tamai K, et al. Transplanted bone marrow⁃derived circulating PDGFRα+ cells restore type Ⅶ collagen in recessive dystrophic epidermolysis bullosa mouse skin graft[J]. J Immunol, 2015,194(4):1996⁃2003. doi: 10.4049/jimmunol. 1400914.
|
[22] |
Nakayama C, Fujita Y, Matsumura W, et al. The development of induced pluripotent stem cell⁃derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes[J]. J Dermatol Sci, 2018,91(3):301⁃310. doi: 10. 1016/j.jdermsci.2018.06.004.
|
[23] |
Tolar J, McGrath JA, Xia L, et al. Patient⁃specific naturally gene⁃reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa[J]. J Invest Dermatol, 2014,134(5):1246⁃1254. doi: 10.1038/jid.2013.523.
|
[24] |
Wenzel D, Bayerl J, Nyström A, et al. Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa[J]. Sci Transl Med, 2014,6(264):264ra165. doi: 10.1126/ scitranslmed.3010083.
|
[25] |
Sebastiano V, Zhen HH, Haddad B, et al. Human COL7A1⁃corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa[J]. Sci Transl Med, 2014,6(264):264ra163. doi: 10.1126/scitranslmed.3009540.
|
[26] |
Shinkuma S, Guo Z, Christiano AM. Site⁃specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa[J]. Proc Natl Acad Sci U S A, 2016,113(20):5676⁃5681. doi: 10.1073/pnas.15120 28113.
|
[27] |
Nguyen HV, Li Y, Tsang SH. Patient⁃specific iPSC⁃derived RPE for modeling of retinal diseases[J]. J Clin Med, 2015,4(4):567⁃578. doi: 10.3390/jcm4040567.
|